Fertility and Sterility
Volume 77 , Pages 42-48 , April 2002

Hormones, mood, sexuality, and the menopausal transition

Presented at the Androgen Insufficiency Conference, Princeton, New Jersey, June 29, 2001.

  • Lorraine Dennerstein, M.B., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Lorraine Dennerstein, M.D., Office for Gender and Health, 6th Floor, Charles Connibere Building, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia (FAX: 61-3-9347-4127)
    • Office for Gender and Health, Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
  • ,
  • John Randolph, M.D.

      Affiliations

    • Office for Gender and Health, Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
  • ,
  • John Taffe, Ph.D.

      Affiliations

    • Swinburne University of Technology, Hawthorn, Victoria, Australia
  • ,
  • Emma Dudley, B.Sc.

      Affiliations

    • Office for Gender and Health, Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
  • ,
  • Henry Burger, M.D.

      Affiliations

    • Prince Henry’s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia

Received 16 October 2001 ,Revised 17 January 2001 ,Accepted 17 January 2001.

References 

  1. Davis SR, Burger HG. Androgens and the postmenopausal woman. J Clin Endocrinol Metab. 1996;81:2759–2764
  2. Davis SR. Androgen treatment in women. Med J Aust. 1999;170:545–549
  3. Randolph J, Dennerstein L. Medscape editorial. Female androgen deficiency syndrome (a hard look at a sexy issue). In: Available at: http://www.medscape.com/medscape/WomensHealth/journal/2001/v06.n02/wh7632.rand.01/wh7632.rand.html.. 2001;
  4. Dennerstein L. Medscape conference report (androgen deficiency in women: definition, diagnosis and classification). In: Available at: http://www.medscape.com/Medscape/CNO/2001/Androgen/public/toc-Androgen.html. 2001;
  5. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85:2832–2838
  6. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995;80:1429–1430
  7. Carlstrom K, Brody S, Lunell NO, Lagrelius G, Mollerstrom A, Pousette G, et al.  Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum (differences related to age and sex). Maturitas. 1988;10:297–306
  8. Ravaglia G, Forti P, Maioli F, Boschi F, Bernardi M, Pratelli L, et al.  The relationship of dehydroepiandrosterone sulphate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over ninety-year-olds. J Clin Endocrinol Metab. 1996;81:1173–1178
  9. Judd HL, Yen SSC. Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab. 1973;36:475–481
  10. Ankarberg C, Norjavaara E. Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls (correlation with 17beta-estradiol and dehydroepiandrosterone sulfate). J Clin Endocrinol Metab. 1999;84:975–984
  11. Sanders D, Bancroft J. Hormones and the sexuality of women—the menstrual cycle. J Clin Endocrinol Metab. 1982;11:639–659
  12. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril. 1996;65:721–723
  13. Kaplan HS, Owett T. The female androgen deficiency syndrome. J Sex Marital Ther. 1993;19:3–24
  14. Morris NM, Udry JR, Khan-Dawood F, Dawood MY. Marital sex frequency and midcycle female testosterone. Arch Sex Behav. 1987;16:27–38
  15. Persky H, Lief AI, Strauss D, Miller WR, O’Brien CP. Plasma testosterone levels and sexual behavior of couples. Arch Sex Behav. 1978;7:157–173
  16. Van Goozen SHM, Wiegant VM, Endert E, Helmond FA, Van de Poll NE. Psychoendocrinological assessment of the menstrual cycle (the relationship between hormones, sexuality, and mood). Arch Sex Behav. 1997;26:359–382
  17. Riley A, Riley E. Controlled studies on women presenting with sexual drive disorder (I. Endocrine status). J Sex Marital Ther. 2000;26:269–283
  18. Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Androgen status and sexual life in perimenopausal women. Menopause. 1997;4:95–100
  19. Eriksson E, Sundblad C, Lisjo P, Modigh K, Andersch B. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology. 1992;17:195–204
  20. Bachmann GA, Leiblum SR, Kemmann E, Colburn DW, Swartzman L, Shelden R. Sexual expression and its determinants in the post-menopausal woman. Maturitas. 1984;6:19–29
  21. Cutler WB, Garcia CR, Huggins GR, Preti G. Sexual behavior and steroid levels among gynecologically premature premenopausal women. Fertil Steril. 1986;48:496–502
  22. Schreiner-Engel P, Schiavi RC, White D, Ghizzani A. Low sexual desire in women (the role of reproductive hormones). Horm Behav. 1989;23:221–234
  23. Bancroft J, Sherwin B, Alexander GM, Davidson DW, Walker A. Oral contraceptives, androgens, and the sexuality of young women. II. The role of androgens. Arch Sex Behav. 1991;20:121–135
  24. Cawood EHH, Bancroft J. Steroid hormones, the menopause, sexuality and wellbeing of women. Psychol Med. 1996;26:925–936
  25. Dennerstein L, Lehert P, Dudley E, Guthrie J. Factors contributing to positive mood during the menopausal transition. J Nerv Ment Dis. 2001;189:84–89
  26. Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis. 1999;187:685–691
  27. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during the midlife years due to ageing or menopause?. Fertil Steril. 2001;76:456–460
  28. Burger H, Dudley E, Hopper J, Groome N, Guthrie J, Green A, et al.  Prospectively measured levels of serum FSH, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab. 1999;84:4025–4030
  29. Dennerstein L, Smith AMA, Morse CA, Burger H. Sexuality and the menopause. J Psychosom Obstet Gynaecol. 1994;15:59–66
  30. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, et al.  The endocrinology of the menopausal transition (a cross-sectional study of a population-based sample). J Clin Endocrinol Metab. 1995;80:3537–3545
  31. McCoy N, Matyas J. Oral contraceptives and sexuality in university women. Arch Sex Behav. 1996;25:73–79
  32. Dennerstein L, Dudley E, Hopper J, Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 1997;26:83–93
  33. Dennerstein L, Lehert P, Dudley E. Short scale to measure female sexuality (adapted from McCoy Female Sexuality questionnaire). J Sex Marital Ther. 2001;27:339–351
  34. Kammann R, Flett R. Affectometer 2: a scale to measure current level of general happiness. Aust Psychol. 1983;35:259–265
  35. Dennerstein L, Smith A, Morse C. Psychological well-being, mid-life and the menopause. Maturitas. 1994;20(1):1–11
  36. Dennerstein L, Anderson-Hunt M, Dudley E, Derogatis L. Evaluation of a short scale to assess female sexual functioning. J Sex Marital Ther. Submitted.
  37. Davis SR, McCloud P, Strauss BJG, Burger H. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas. 1995;21:227–236
  38. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. J Reprod Med. 1998;43:847–856
  39. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females (a prospective, crossover study of sex steroid administration in the surgical menopause). Psychosom Med. 1985;47:339–351
  40. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al.  Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–688
  41. Baulieu E, Thomas G, Legrain S, Lahlou N, Roger N, Debuire B. Dehydroepiandrosterone (DHEA), DHEA sulphate, and aging (contribution of the DHEAge Study to a sociobiomedical issue). Proc Natl Acad Sci U S A. 2000;97:4279–4284
  42. Dennerstein L, Burrows GD, Hyman G, Sharpe K. Hormone therapy and affect. Maturitas. 1979;1:247–259
  43. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K. Hormones and sexuality (effects of estrogen and progesterone). Obstet Gynecol. 1980;56:316–322
  44. Dennerstein L, Lehert P, Burger H, Dudley E. Factors affecting sexual functioning of women in the midlife years. Climacteric. 1999;2:254–262

 Supported by the National Health and Medical Research Council of Australia and the Victorian Health Promotion Foundation. During 2001, the research program received unrestricted educational grants from ANZ Trustees, Eli Lilly (Australia) Proprietary Limited, and Pharmacia and Upjohn (Australia). Prince Henry’s Institute of Medical Research received grants from Organon Proprietary Limited for hormone assays.

PII: S0015-0282(02)03001-7

Fertility and Sterility
Volume 77 , Pages 42-48 , April 2002